Cetera Trust Company N.A Has $355,000 Stock Holdings in CVS Health Co. (NYSE:CVS)

Cetera Trust Company N.A reduced its stake in CVS Health Co. (NYSE:CVS) by 53.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,918 shares of the pharmacy operator’s stock after selling 9,125 shares during the period. Cetera Trust Company N.A’s holdings in CVS Health were worth $355,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. ProShare Advisors LLC boosted its position in CVS Health by 9.0% during the second quarter. ProShare Advisors LLC now owns 209,881 shares of the pharmacy operator’s stock valued at $12,396,000 after acquiring an additional 17,281 shares during the last quarter. Frank Rimerman Advisors LLC grew its position in shares of CVS Health by 9,318.2% during the 2nd quarter. Frank Rimerman Advisors LLC now owns 9,324 shares of the pharmacy operator’s stock worth $551,000 after buying an additional 9,225 shares during the period. EverSource Wealth Advisors LLC lifted its position in shares of CVS Health by 12.6% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 15,618 shares of the pharmacy operator’s stock valued at $942,000 after acquiring an additional 1,753 shares during the period. Lombard Odier Asset Management Europe Ltd boosted its stake in CVS Health by 29.9% during the second quarter. Lombard Odier Asset Management Europe Ltd now owns 30,099 shares of the pharmacy operator’s stock worth $1,778,000 after acquiring an additional 6,927 shares in the last quarter. Finally, Bank of Montreal Can grew its holdings in CVS Health by 2.4% in the second quarter. Bank of Montreal Can now owns 2,436,343 shares of the pharmacy operator’s stock worth $143,890,000 after purchasing an additional 57,214 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently commented on CVS shares. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $60.00 to $66.00 in a research note on Monday, November 18th. Royal Bank of Canada reduced their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a report on Friday, November 15th. Mizuho decreased their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. TD Cowen lifted their target price on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, November 25th. Finally, UBS Group boosted their price target on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. One analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $68.71.

CVS Health Stock Performance

Shares of NYSE:CVS opened at $52.80 on Wednesday. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company has a market cap of $66.45 billion, a price-to-earnings ratio of 13.37, a price-to-earnings-growth ratio of 0.79 and a beta of 0.59. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a 50-day moving average price of $51.26 and a 200-day moving average price of $56.26.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period last year, the company earned $2.21 EPS. As a group, equities analysts anticipate that CVS Health Co. will post 5.22 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be issued a dividend of $0.665 per share. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.04%. CVS Health’s dividend payout ratio (DPR) is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.